Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16087890Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,760
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Michael Honigberg as a PI. Multi-PI records show the full award amount for context.
- 1R01HL173028-01A1R01Effects of IL-1 beta inhibition on vascular inflammation in TET2 clonal hematopoiesis$834.5Kaward amount
- 1R01HL181150-01R01Cardiac Effects of Mineralocorticoid Receptor Antagonism after Preeclampsia (CARDAMOM)$658.4Kaward amount
- 5K08HL166687-03K08Clonal hematopoiesis as a mediator of cardiovascular disease in women with premature menopause$169Kaward amount
Award organization
Organizations that administered FY2025 awards listing Michael Honigberg as a PI.
FY2025 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardMassachusetts General Hospital
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #8760
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michael Honigberg.